Historical record - last NADAC publication: 5/25/2022
Product Information
MUCINEX FAST-MAX COLD-FLU CAP is a brand product labeled by RB Health (US) LLC, priced at $0.7369 per EA under NDC 72854012616. Its NADAC has been published 56 times since May 25, 2022.
The High Outlier badge above means this manufacturer's average price in the Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
MUCINEX FAST-MAX COLD-FLU CAP
Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine HydrochlorideStrength
325; 10; 200; 5 mg/1; mg/1; mg/1; mg/1
Manufacturer
RB Health (US) LLCNDC
72854012616
Classification
Brand
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Last Updated
5/25/2022
Active Ingredients
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
7/26/2021
Pharmacological Classes
Price Statistics
The NADAC for MUCINEX FAST-MAX COLD-FLU CAP has been published 56 times since May 25, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7369 per EA |
|---|---|
| All-time high | $0.7369 (Jun 14, 2023) |
| All-time low | $0.7369 (May 25, 2022) |
| Median price | $0.7369 |
| Average price | $0.7369 |
| Largest weekly change | 0.0% (Jun 1, 2022) |
| Weeks tracked | 56 |
| Tracking since | May 25, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MUCINEX FAST-MAX COLD-FLU CAP?
The current National Average Drug Acquisition Cost (NADAC) for MUCINEX FAST-MAX COLD-FLU CAP, manufactured by RB Health (US) LLC, is $0.7369 per EA (NDC 72854012616), effective Jun 14, 2023.
How has the price of MUCINEX FAST-MAX COLD-FLU CAP changed over time?
Over the history we have for it, the NADAC for MUCINEX FAST-MAX COLD-FLU CAP has held within roughly two percent of its current level. It has been tracked across 56 weekly CMS publications since May 25, 2022.
What are the highest and lowest recorded NADAC prices for MUCINEX FAST-MAX COLD-FLU CAP?
Since May 25, 2022, the NADAC for MUCINEX FAST-MAX COLD-FLU CAP has ranged from a low of $0.7369 (May 25, 2022) to a high of $0.7369 (Jun 14, 2023), with a median of $0.7369 per EA.
Are there cheaper alternatives to MUCINEX FAST-MAX COLD-FLU CAP?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, MUCINEX FAST-MAX COLD-FLU CPLT, is $0.5594 per EA — about 24% below MUCINEX FAST-MAX COLD-FLU CAP.
Who manufactures MUCINEX FAST-MAX COLD-FLU CAP?
MUCINEX FAST-MAX COLD-FLU CAP (NDC 72854012616) is labeled by RB Health (US) LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification